MYLAN DA 15 MYLAN DA 15 (Dextroamphetamine sulfate extended-release 15 mg)
Pill imprint MYLAN DA 15 MYLAN DA 15 has been identified as Dextroamphetamine sulfate extended-release 15 mg.
Dextroamphetamine is used in the treatment of sexual dysfunction, ssri induced; adhd; narcolepsy; fatigue; hypersomnia and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Dextroamphetamine 15 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- MYLAN DA 15 MYLAN DA 15
- Strength:
- 15 mg
- Color:
- Brown & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- CNS stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Manufacturer:
- Mylan Pharmaceuticals Inc.
More about dextroamphetamine
Consumer resources
- Dextroamphetamine
- Dextroamphetamine solution
- Dextroamphetamine sustained-release capsules
- Dextroamphetamine (Advanced Reading)
- Other brands: Dexedrine, Zenzedi, Dextrostat, ProCentra, More (1) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
